Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report

被引：17

作者：

Sossa Melo, Claudia Lucia ^{[1
,2
]}

Maria Pena, Angela ^{[1
,2
]}

Antonio Salazar, Luis ^{[1
,2
]}

Ines Jimenez, Sara ^{[1
,2
]}

David Gomez, Edgar ^{[3
]}

Marcela Chalela, Claudia ^{[1
]}

Ayala-Castillo, Miguel ^{[3
]}

Mauricio Pena, Ivan ^{[4
,5
]}

机构：

[1] Univ Autonoma Bucaramanga, Sch Med, Dept Internal Med, Div Hematol & Hematopoiet Stem Cell Transplantat, Bucaramanga, Colombia

[2] Clin FOSCAL, Hematol & Stem Cell Transplantat Unit, Carrera 24 154-106,Edificio Milton Salazar, Bucaramanga, Colombia

[3] Clin FOSCAL, Dept Internal Med, Bucaramanga, Colombia

[4] Clin FOSCAL, Dept Neurol, Bucaramanga, Colombia

[5] Univ Autonoma Bucaramanga, Sch Med, Dept Internal Med, Div Neurol, Bucaramanga, Colombia

来源：

NEUROMUSCULAR DISORDERS | 2019年 / 29卷 / 02期

关键词：

Miastenia gravis; Refractory; Autologous hematopoietic stem cell transplantation; Treatment; AUTOIMMUNE-DISEASES; MARROW TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; EUROPEAN GROUP; RITUXIMAB; GUIDELINES; BLOOD; TRIAL; SCT;

D O I：

10.1016/j.nmd.2018.11.008

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Myasthenia gravis is a neuromuscular autoimmune disease characterized by fatigable weakness of skeletal muscles that results from an antibody-mediated immunological attack directed at acetylcholine postsynaptic receptors. Autologous hematopoietic stem cell transplantation is considered as a treatment option in refractory cases of myasthenia gravis. A 56-year-old Colombian male presented with six months of progressive hoarseness and dysphagia, with a positive repetitive stimulation test suggestive of end plate neuromuscular disease. Myasthenia gravis was confirmed with serology testing that reported presence of circulating acetylcholine postsynaptic receptors antibodies. The patient received several lines of pharmacological treatment and thymectomy without control of symptoms, requiring admission to the intensive care unit and mechanical ventilation in two occasions. Patient underwent autologous hematopoietic stem cell transplantation and has been in complete clinical remission for 65 months. Hematopoietic stem cell transplantation is a well-tolerated treatment that should be considered over conventional therapy in selected patients with refractory myasthenia gravis. (C) 2018 Elsevier B.V. All rights reserved.

引用

页码：142 / 145

页数：4

共 25 条

[1] SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking [J].

Alexander, T. ;

Bondanza, A. ;

Muraro, P. A. ;

Greco, R. ;

Saccardi, R. ;

Daikeler, T. ;

Kazmi, M. ;

Hawkey, C. ;

Simoes, P. ;

Leblanc, K. ;

Fibbe, W. E. ;

Moore, J. ;

Snarski, E. ;

Martin, T. ;

Hiepe, F. ;

Velardi, A. ;

Toubert, A. ;

Snowden, J. A. ;

Farge, D. .

BONE MARROW TRANSPLANTATION, 2015, 50 (02) :173-180

[2] Rituximab in refractory myasthenia gravis: a prospective, open-label study with long-term follow-up [J].

Anderson, Dustin ;

Phan, Cecile ;

Johnston, Wendy S. ;

Siddiqi, Zaeem A. .

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (07) :552-555

[3] Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation [J].

Bryant, Adam ;

Atkins, Harold ;

Pringle, C. Elizabeth ;

Allan, David ;

Anstee, Grizel ;

Bence-Bruckler, Isabelle ;

Hamelin, Linda ;

Hodgins, Michael ;

Hopkins, Harry ;

Huebsch, Lothar ;

McDiarmid, Sheryl ;

Sabloff, Mitchell ;

Sheppard, Dawn ;

Tay, Jason ;

Bredeson, Christopher .

JAMA NEUROLOGY, 2016, 73 (06) :652-658

[4] Frequency of seronegativity in adult-acquired generalized myasthenia gravis [J].

Chan, Koon Ho ;

Lachance, Daniel H. ;

Harper, C. Michel ;

Lennon, Vanda A. .

MUSCLE & NERVE, 2007, 36 (05) :651-658

[5] Rituximab: clinical development and future directions [J].

Cheson, BD .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) :97-110

[6] Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network [J].

de Kleer, I ;

Vastert, B ;

Klein, M ;

Teklenburg, G ;

Arkesteijn, G ;

Yung, GP ;

Albani, S ;

Kuis, W ;

Wulffraat, N ;

Prakken, B .

BLOOD, 2006, 107 (04) :1696-1702

[7] Long-lasting treatment effect of rituximab in MuSK myasthenia [J].

Diaz-Manera, J. ;

Martinez-Hernandez, E. ;

Querol, L. ;

Klooster, R. ;

Rojas-Garcia, R. ;

Suarez-Calvet, X. ;

Munoz-Blanco, J. L. ;

Mazia, C. ;

Straasheijm, K. R. ;

Gallardo, E. ;

Juarez, C. ;

Verschuuren, J. J. ;

Illa, I. .

NEUROLOGY, 2012, 78 (03) :189-193

[8] Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for Blood and Marrow Transplantation Working Party on Autoimmune Diseases [J].

Farge, Dominique ;

Labopin, Myriam ;

Tyndall, Alan ;

Fassas, Athanasios ;

Mancardi, Gian Luigi ;

Van Laar, Jaap ;

Jian Ouyang ;

Kozak, Tomas ;

Moore, John ;

Koetter, Ina ;

Chesnel, Virginie ;

Marmont, Alberto ;

Gratwohl, Alois ;

Saccardi, Riccardo .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02) :284-292

[9] Myasthenia gravis: subgroup classification and therapeutic strategies [J].

Gilhus, Nils Erik ;

Verschuuren, Jan J. .

LANCET NEUROLOGY, 2015, 14 (10) :1023-1036

[10] Successful autologous haematopoietic stem cell transplantation for refractory myasthenia gravis - a case report [J].

Hakansson, Irene ;

Sandstedt, Anna ;

Lundin, Fredrik ;

Askmark, Hakan ;

Pirskanen, Ritva ;

Carlson, Kristina ;

Piehl, Fredrik ;

Hagglund, Hans .

NEUROMUSCULAR DISORDERS, 2017, 27 (01) :90-93

← 1 2 3 →